Edward O’Mara

2.1k citations

46 papers · 1.6k indexed · h-index 21

Co-authors: Stephen D. Hall Lei Ma Gopal Krishna Jack Gorski D. I. Jones Mitchell A. Hamman Monika Martinho Richard A. Preston
Topics: HIV/AIDS drug development and treatment (12 papers)Hepatitis C virus research (11 papers)Pharmaceutical studies and practices (6 papers)
Cited by: Pharmacology Infectious Diseases Virology
Journals: Journal of Clinical Oncology Blood Gastroenterology
Partner nations: United States Netherlands Canada

In The Last Decade

Edward O’Mara

46 papers receiving 1.6k citations

Peers

Countries citing papers authored by Edward O’Mara

Since Specialization

Citations

This map shows the geographic impact of Edward O’Mara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward O’Mara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward O’Mara more than expected).

Fields of papers citing papers by Edward O’Mara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward O’Mara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward O’Mara. The network helps show where Edward O’Mara may publish in the future.

Co-authorship network of co-authors of Edward O’Mara

This figure shows the co-authorship network connecting the top 25 collaborators of Edward O’Mara. A scholar is included among the top collaborators of Edward O’Mara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward O’Mara. Edward O’Mara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells 2017 ·Blood ·Liangxian Cao,Arthur Branstrom,John D. Baird,Christopher R. Trotta,Joseph M. Colacino,(unknown),(unknown),Mark Ma,Kensuke Kojima,Stuart W. Peltz,Edward O’Mara,Robert J. Spiegel,Marla Weetall	1
2	Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function 2017 ·Clinical Pharmacology Advances and Applications ·Yan Li,Xiaomin Wang,Edward O’Mara,Meletios Α. Dimopoulos,Pieter Sonneveld,Katja Weisel,Jeffrey Matous,David S. Siegel,Jatin J. Shah,(unknown),Lars Sternås,(unknown),Mohamed H. Zaki,Maria Palmisano,Simon Zhou	10
3	Initial first-in-human phase 1 results of PTC596, a novel small molecule that targets cancer stem cells (CSCs) by reducing BMI1 protein levels 2016 ·Annals of Oncology ·Geoffrey I. Shapiro,Jon Infante,Todd M. Bauer,Amy Prawira,(unknown),O. L. Laskin,Marla Weetall,John D. Baird,Edward O’Mara,Robert J. Spiegel	2
4	A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects 2016 ·Cancer Chemotherapy and Pharmacology ·(unknown),(unknown),Liangang Liu,Edward O’Mara	5
5	Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy 2015 ·European Journal of Clinical Pharmacology ·Ellen G. J. Hulskotte,R. Douglas Bruce,Hwa-ping Feng,Lynn R. Webster,(unknown),(unknown),Edward O’Mara,John A. Wagner,Joan R. Butterton	13
6	Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects 2014 ·Antimicrobial Agents and Chemotherapy ·Wendy M. Kersemaekers,Thijs van Iersel,U. K. Nässander,Edward O’Mara,Hetty Waskin,Maria Caceres,Marlou L. P. S. van Iersel	56
7	Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir 2012 ·Clinical Infectious Diseases ·Ellen G. J. Hulskotte,Hwa-ping Feng,Fengjuan Xuan,(unknown),Michelle Treitel,Eric Hughes,Edward O’Mara,Stephen P. Youngberg,John A. Wagner,Joan R. Butterton	58
8	Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function 2012 ·Clinical Pharmacokinetics ·Michelle Treitel,Thomas Marbury,Richard A. Preston,(unknown),William F. Feely,Edward O’Mara,Claudia Kasserra,Samir K. Gupta,Eric Hughes	34
9	Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers 2012 ·Hepatology ·Ellen G. J. Hulskotte,Samir K. Gupta,Fengjuan Xuan,(unknown),Edward O’Mara,Hwa-ping Feng,John A. Wagner,Joan R. Butterton	78
10	Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers 2011 ·Expert Opinion on Drug Metabolism & Toxicology ·Gopal Krishna,Lei Ma,(unknown),Allen Moton,Monika Martinho,Edward O’Mara	35
11	Effect of Vicriviroc With or Without Ritonavir on Oral Contraceptive Pharmacokinetics: A Randomized, Open-Label, Parallel-Group, Fixed-Sequence Crossover Trial in Healthy Women 2011 ·Clinical Therapeutics ·Claudia Kasserra,Jing Li,(unknown),Edward O’Mara	12
12	Renal Insufficiency Has No Effect on the Pharmacokinetics of Vicriviroc in a Ritonavir-Containing Regimen 2010 ·Clinical Pharmacokinetics ·Claudia Kasserra,Angela Sansone‐Parsons,Anther Keung,Ernestina Tetteh,(unknown),Edward O’Mara,Thomas Marbury	5
13	The Effect of Ravuconazole on the Pharmacokinetics of Nelfinavir in Healthy Male Volunteers 2006 ·The Journal of Clinical Pharmacology ·(unknown),Maria R. Marino,Robert A. Smith,(unknown),Edward O’Mara,Dennis M. Grasela	11
14	Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction 2005 ·AIDS ·Gerald Friedland,Laurie Andrews,(unknown),(unknown),(unknown),Michael Child,Julia Shi,Yonghua Wang,Edward O’Mara	39
15	The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults 2004 ·AIDS ·Mustafa A. Noor,Rex A. Parker,Edward O’Mara,Dennis M. Grasela,Alexander Currie,Sally Hodder,Fred T. Fiedorek,David W. Haas	155
16	Hollow‐Fiber Unit Evaluation of a New Human Immunodeficiency Virus Type 1 Protease Inhibitor, BMS‐232632, for Determination of the Linked Pharmacodynamic Variable 2001 ·The Journal of Infectious Diseases ·George L. Drusano,John A. Bilello,Sandra L. Preston,Edward O’Mara,Sanjeev Kaul,S. Schnittman,Roger Echols	44
17	Prevention of ExperimentalHaemophilus ducreyiInfection: A Randomized, Controlled Clinical Trial 1998 ·The Journal of Infectious Diseases ·Alice Thornton,Edward O’Mara,(unknown),Thomas J. Hiltke,Kate R. Fortney,Barry P. Katz,Ronald E. Shoup,Antoinette F. Hood,Stanley M. Spinola	27
18	Use of an Estimation Method to Derive an Appropriate Denominator to Calculate Central Venous Catheter-Associated Bloodstream Infection Rates 1998 ·Infection Control and Hospital Epidemiology ·Susan Temporado Cookson,Melanie Ihrig,Edward O’Mara,Alan I. Hartstein,William R. Jarvis	9
19	Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation* 1996 ·Clinical Pharmacology & Therapeutics ·David R. Jones,J. Christopher Gorski,(unknown),Edward O’Mara,Stephen D. Hall	58
20	Delayed Onset of Angioedema with Angiotensin‐Converting Enzyme Inhibitors: Case Report and Review of the Literature 1996 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown),Edward O’Mara	21

About Edward O’Mara

Edward O’Mara is a scholar working on Hepatology, Virology and Infectious Diseases, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), Hepatitis C virus research (11 papers) and Pharmaceutical studies and practices (6 papers). The work is most often cited by research in Pharmacology (369 citations), Infectious Diseases (668 citations) and Virology (149 citations). Edward O’Mara has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Stephen D. Hall, Lei Ma, Gopal Krishna, Jack Gorski, D. I. Jones, Mitchell A. Hamman, Monika Martinho, Richard A. Preston, M. Martinho and Dennis M. Grasela. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact